title: FDA approval process: meeting the need for promising therapeutics for patients with serious and life-threatening disease. An NCCN roundtable discussion.
mesh_terms: D000970:Antineoplastic Agents; D017277:Drug Approval / Q000331:legislation & jurisprudence; D023381:Endpoint Determination; D006801:Humans; D010372:Pediatrics; D013997:Time Factors; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000970:Antineoplastic Agents